| Mepha Pharma AG - Valganciclovir-Mepha 450, Filmtabletten | | 65032 | | 01 | | Valganciclovir-Mepha 450 | | Filmtabletten | | J05AB14 | | Valganciclovir | | 15.05.2014 | | |
| | Composition | | valganciclovirum 450 mg ut valgancicloviri hydrochloridum 496.3 mg, cellulosum microcristallinum, mannitolum, magnesii stearas, silica colloidalis anhydrica, crospovidonum, Überzug: hypromellosum, lactosum monohydricum 6.7 mg, triacetinum, E 171, E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Valganciclovir | 450 mg |
| | BAG: Active Agent | Dose |
|---|
| Valganciclovir | 450 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 6.7 mg | | | Magnesii Stearas | | | | Mannitol | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 60 Tablet(s) | 1054.01 | 1162.70 | A | SL | Yes |
|
|
